0R2M fundamentals
An in-depth look to REGENERON PHARMACEUTICALS INC COM STK USD0.001 operating, investing, and financing activities
0R2M free cash flow for Q1 24 is 1.38 B USD. For 2023, 0R2M free cash flow was 3.88 B USD and operating cash flow was 4.59 B USD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM